Along with enhanced infiltration of these T cells into tumours, CD11c-specific loss of MK2 resulted in the generation of a clonally expanded, less exhausted T cell population, altogether reinstating immune control over tumour progression. The gene discussed is MAPKAPK2; the disease is neoplasm.